1. https://beckleyfoundation.org/psilocybin-for-depression-2/Minusta aivoja ja keskushermostoa ei kannata alkaa sorkkia ilman todella vakavia läketieteellisiä perusteita.
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study | The Beckley Foundation
Authors: Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding, David Taylor, Steve
beckleyfoundation.org
2. https://www.kcl.ac.uk/ioppn/depts/pm/research/cfad/psilocybin-trials
3 https://www.healthline.com/health-news/fda-looking-at-magic-mushroom-ingredient-to-treat-depression
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Cancer patients often develop chronic, clinically significant symptoms of depression and anxiety. Previous studies suggest that psilocybin may decrease depression and anxiety in cancer patients. The effects of psilocybin were studied in 51 cancer patients ...
www.ncbi.nlm.nih.gov
Jos haluat lisää tutkimuksia, voin kaivaa niitä esille.